TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Digestive System Department
Division of General Internal Medicine
更新時間：2023-09-19
高嘉宏Kao, Jia-Horng
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
Publication
53Publications
31
Chang WY, Chiu YC, Chiu FW, Hsu YC, Tseng TC, Cheng PN, Yang SS, Liu CJ, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy. J Infect Dis. 2020 Sep 14;222(8):1345-1352. doi: 10.1093/infdis/jiaa256. PMID: 32396638.
32
Hong TC, Yang HC, Chen CL, Kao JH, Liu CJ, Chen MJ, Wang HY, Kuo YC, Yu LY, Hu KC. Relationship between serum gamma-glutamyl transferase level and colorectal adenoma. PLoS One. 2020 Oct 13;15(10):e0240445. doi: 10.1371/journal.pone.0240445. PMID: 33048943; PMCID: PMC7553303.
33
Kao JH, Hu TH, Jia J, Kurosaki M, Lim YS, Lin HC, Sinn DH, Tanaka Y, Wai-Sun Wong V, Yuen MF. East Asia expert opinion on treatment initiation for chronic hepatitis B. Aliment Pharmacol Ther. 2020 Nov;52(10):1540-1550. doi: 10.1111/apt.16097. Epub 2020 Sep 20. PMID: 32951256.
34
Wang CC, Tzeng IS, Su WC, Li CH, Lin HH, Yang CC, Kao JH. The association of vitamin D with hepatitis B virus replication: Bystander rather than offender. J Formos Med Assoc. 2020 Nov;119(11):1634-1641. doi: 10.1016/j.jfma.2019.12.004. Epub 2020 Jan 10. PMID: 31932201.
35
APASL Covid-19 Task Force, Lau G, Sharma M. Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations. Hepatol Int. 2020 Jul;14(4):415-428. doi: 10.1007/s12072-020-10054-w. Epub 2020 May 23. PMID: 32447721; PMCID: PMC7245190.
36
Yang YC, Chen YH, Kao JH, Ching C, Liu IJ, Wang CC, Tsai CH, Wu FY, Liu CJ, Chen PJ, Chen DS, Yang HC. Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing. Mol Ther Nucleic Acids. 2020 Jun 5;20:480-490. doi: 10.1016/j.omtn.2020.03.005. Epub 2020 Mar 19. PMID: 32278307; PMCID: PMC7150432.
37
Hong CM, Liu CH, Su TH, Yang HC, Chen PJ, Chen YW, Kao JH, Liu CJ. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data. J Microbiol Immunol Infect. 2020 Aug;53(4):569-577. doi: 10.1016/j.jmii.2018.09.005. Epub 2018 Sep 26. PMID: 30316726.
38
Lin CL, Kao JH. Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence. Gastroenterol Clin North Am. 2020 Jun;49(2):201-214. doi: 10.1016/j.gtc.2020.01.010. PMID: 32389359.
39
Huang SC, Yang HC, Kao JH. Hepatitis B reactivation: diagnosis and management. Expert Rev Gastroenterol Hepatol. 2020 Jul;14(7):565-578. doi: 10.1080/17474124.2020.1774364. Epub 2020 Jun 16. PMID: 32448008.
40
Hsu WF, Chen CY, Tseng KC, Lai HC, Kuo HT, Hung CH, Tung SY, Wang JH, Chen JJ, Lee PL, Chien RN, Lin CY, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Su WW, Chu CH, Chen CJ, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Tsai PC, Huang JF, Dai CY, Chuang WL, Yu ML, Peng CY. Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis. Sci Rep. 2020 Mar 25;10(1):5372. doi: 10.1038/s41598-020-61991-3. PMID: 32214132; PMCID: PMC7096452.
